Published in J Control Release on May 14, 2001
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov (2014) 2.20
In situ-gelling, erodible N-isopropylacrylamide copolymers. Macromol Biosci (2005) 1.44
Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release (2011) 1.39
Engineered polymers for advanced drug delivery. Eur J Pharm Biopharm (2008) 1.17
Paclitaxel Nano-Delivery Systems: A Comprehensive Review. J Nanomed Nanotechnol (2013) 1.16
Injectable intratumoral depot of thermally responsive polypeptide-radionuclide conjugates delays tumor progression in a mouse model. J Control Release (2010) 1.15
Materials for diabetes therapeutics. Adv Healthc Mater (2012) 1.14
Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles. BMC Cancer (2008) 1.06
A novel thermosensitive polymer with pH-dependent degradation for drug delivery. Acta Biomater (2009) 1.01
Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advances. AAPS PharmSciTech (2008) 1.01
HYDROGELS FROM SOFT CONTACT LENSES AND IMPLANTS TO SELF-ASSEMBLED NANOMATERIALS. J Polym Sci A Polym Chem (2009) 0.99
Biomaterial selection for tooth regeneration. Tissue Eng Part B Rev (2011) 0.98
Bioactive factor delivery strategies from engineered polymer hydrogels for therapeutic medicine. Prog Polym Sci (2014) 0.92
Long-term delivery of protein therapeutics. Expert Opin Drug Deliv (2014) 0.91
Preparation and investigation of sustained drug delivery systems using an injectable, thermosensitive, in situ forming hydrogel composed of PLGA-PEG-PLGA. AAPS PharmSciTech (2012) 0.87
Bioengineering strategies for designing targeted cancer therapies. Adv Cancer Res (2013) 0.86
In vivo evaluation of injectable thermosensitive polymer with time-dependent LCST. J Biomed Mater Res A (2009) 0.86
Accelerated in-vitro release testing methods for extended-release parenteral dosage forms. J Pharm Pharmacol (2012) 0.86
Delayed onset of paresis in rats with experimental intramedullary spinal cord gliosarcoma following intratumoral administration of the paclitaxel delivery system OncoGel. J Neurosurg Spine (2012) 0.84
Self-assembled nanoplatform for targeted delivery of chemotherapy agents via affinity-regulated molecular interactions. Biomaterials (2010) 0.84
Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect. BMC Biotechnol (2008) 0.84
Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft. J Control Release (2010) 0.84
In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation. J Bioequiv Availab (2009) 0.84
Evaluation of intratympanic formulations for inner ear delivery: methodology and sustained release formulation testing. Drug Dev Ind Pharm (2013) 0.83
In vivo evaluation of the delivery and efficacy of a sirolimus-laden polymer gel for inhibition of hyperplasia in a porcine model of arteriovenous hemodialysis graft stenosis. J Control Release (2012) 0.83
Tumor regression achieved by encapsulating a moderately soluble drug into a polymeric thermogel. Sci Rep (2014) 0.82
Adjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrix. PLoS One (2013) 0.81
Accelerating protein release from microparticles for regenerative medicine applications. Mater Sci Eng C Mater Biol Appl (2013) 0.81
Development of hydrophobized alginate hydrogels for the vessel-simulating flow-through cell and their usage for biorelevant drug-eluting stent testing. AAPS PharmSciTech (2013) 0.80
Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug delivery. Acta Biomater (2011) 0.79
Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model. J Neurooncol (2012) 0.79
Efficacy, pharmacokinetics, and biodistribution of thermosensitive chitosan/β-glycerophosphate hydrogel loaded with docetaxel. AAPS PharmSciTech (2014) 0.79
Release and activity of anti-TNFalpha therapeutics from injectable chitosan preparations for local drug delivery. J Biomed Mater Res B Appl Biomater (2009) 0.79
Advances in endoscopic ultrasound, part 2: Therapy. Can J Gastroenterol (2009) 0.78
Pathogenesis and local drug delivery for prevention of vascular access stenosis. J Ren Nutr (2008) 0.78
PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery. J Control Release (2015) 0.78
Hydrogels composed of cyclodextrin inclusion complexes with PLGA-PEG-PLGA triblock copolymers as drug delivery systems. AAPS PharmSciTech (2014) 0.77
Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery. J Control Release (2016) 0.77
Sustained subconjunctival protein delivery using a thermosetting gel delivery system. J Ocul Pharmacol Ther (2010) 0.77
Controlled block copolymer micelle formation for encapsulation of hydrophobic ingredients. Eur Phys J E Soft Matter (2013) 0.77
Nanoparticle tumor localization, disruption of autophagosomal trafficking, and prolonged drug delivery improve survival in peritoneal mesothelioma. Biomaterials (2016) 0.76
Preparation of a sustained release drug delivery system for dexamethasone by a thermosensitive, in situ forming hydrogel for use in differentiation of dental pulp. ISRN Pharm (2013) 0.76
Post-lumpectomy intracavitary retention and lymph node targeting of (⁹⁹m)Tc-encapsulated liposomes in nude rats with breast cancer xenograft. Breast Cancer Res Treat (2010) 0.76
Controlled release of liraglutide using thermogelling polymers in treatment of diabetes. Sci Rep (2016) 0.75
Assessment of PLGA-PEG-PLGA copolymer hydrogel for sustained drug delivery in the ear. Curr Drug Deliv (2014) 0.75
Mechanistic analysis of Zein nanoparticles/PLGA triblock in situ forming implants for glimepiride. Int J Nanomedicine (2016) 0.75
Synthesis and biocompatibility of a biodegradable and functionalizable thermo-sensitive hydrogel. Regen Biomater (2015) 0.75
Pharmaceutical organogels prepared from aromatic amino acid derivatives. J Mater Chem (2009) 0.75
Platelet-Rich Plasma-Loaded Poly(d,l-lactide)-Poly(ethylene glycol)-Poly(d,l-lactide) Hydrogel Dressing Promotes Full-Thickness Skin Wound Healing in a Rodent Model. Int J Mol Sci (2016) 0.75
Temperature-sensitive star-shaped block copolymers hydrogels for an injection application: phase transition behavior and biocompatibility. J Mater Sci Mater Med (2012) 0.75
Characterizations and bioactivities of abendazole sulfoxide-loaded thermo-sensitive hydrogel. Parasitol Res (2016) 0.75
Self-assembled nanomicelles using PLGA-PEG amphiphilic block copolymer for insulin delivery: a physicochemical investigation and determination of CMC values. J Mater Sci Mater Med (2012) 0.75
A pigment-binding protein essential for regulation of photosynthetic light harvesting. Nature (2000) 6.97
Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell (1982) 6.93
Reovirus messenger RNA contains a methylated, blocked 5'-terminal structure: m-7G(5')ppp(5')G-MpCp-. Proc Natl Acad Sci U S A (1975) 6.26
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature (1982) 6.09
Compulsory averaging of crowded orientation signals in human vision. Nat Neurosci (2001) 5.47
Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci U S A (1979) 5.32
The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol (1987) 5.30
Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J (2001) 5.29
Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature (1981) 4.72
Uncertainty in estimates of HIV/AIDS: the estimation and application of plausibility bounds. Sex Transm Infect (2004) 4.54
Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol (1987) 4.53
Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A (1998) 3.99
The mucosal immune system: from fundamental concepts to vaccine development. Vaccine (1992) 3.99
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. J Clin Oncol (1998) 3.69
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood (1999) 3.46
Keratin cytoskeletons in epithelial cells of internal organs. Proc Natl Acad Sci U S A (1979) 3.45
ACORN group, social class, and child health. J Epidemiol Community Health (1983) 3.27
Measuring social inequality: occupational classifications and their alternatives. Community Med (1983) 3.22
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int (2007) 3.17
Methylated, blocked 5 termini in HeLa cell mRNA. Proc Natl Acad Sci U S A (1975) 3.02
Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum (1976) 2.97
Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate. J Clin Oncol (2001) 2.81
Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci U S A (1998) 2.80
Ingestion of Streptococcus mutans induces secretory immunoglobulin A and caries immunity. Science (1976) 2.78
Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest (1999) 2.77
Influence of subnarcotic doses of Althesin (CT1341) on pain induced by two types of pain stimulus. Br J Anaesth (1973) 2.77
Three different human tumor cell lines contain different oncogenes. Cell (1981) 2.77
Nitrous oxide: time to stop laughing? Anaesthesia (1998) 2.75
Myocardial ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet (1983) 2.70
Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest (1978) 2.64
Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines. J Virol (1998) 2.63
Conducting a matched-pairs historical cohort study with a computer-based ambulatory medical record system. Comput Biomed Res (1990) 2.62
In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release (2001) 2.59
Pathogenic species of the genus Haemophilus and Streptococcus pneumoniae produce immunoglobulin A1 protease. Infect Immun (1979) 2.57
The SF-36 health survey questionnaire: is it suitable for use with older adults? Age Ageing (1995) 2.54
Passive exposure to tobacco smoke: saliva cotinine concentrations in a representative population sample of non-smoking schoolchildren. Br Med J (Clin Res Ed) (1985) 2.51
Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev (1988) 2.50
IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc Natl Acad Sci U S A (1987) 2.37
Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut (2002) 2.29
Secretory component of epithelial cells is a surface receptor for polymeric immunoglobulins. J Exp Med (1978) 2.26
Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol (1999) 2.25
IgA1 proteases from Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Streptococcus sanguis: comparative immunochemical studies. J Immunol (1980) 2.23
Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell (1982) 2.22
Why do mothers consult when their children cough? Fam Pract (1993) 2.21
Use of open standards to implement health maintenance guidelines in a clinical workstation. Comput Biol Med (1994) 2.15
Methyl labeling of HeLa cell hnRNA: a comparison with mRNA. Cell (1976) 2.13
Trophic conversion of an obligate photoautotrophic organism through metabolic engineering. Science (2001) 2.10
The impact of chronic urticaria on the quality of life. Br J Dermatol (1997) 2.08
Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology (2000) 2.07
Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine (1995) 2.06
An evaluation of the Level 1 blood warmer series. Anaesthesia (1990) 2.03
Immunoglobulin M and secretory immunoglobulin A: presence of a common polypeptide chain different from light chains. Science (1971) 2.03
Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. Diabetes (1999) 2.03
Presentation of striatal hyperintensity on T1-weighted MRI in patients with hemiballism-hemichorea caused by non-ketotic hyperglycemia: report of seven new cases and a review of literature. J Neurol (2001) 2.02
IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med (1988) 2.02
Influence of 5'-terminal m7G and 2'--O-methylated residues on messenger ribonucleic acid binding to ribosomes. Biochemistry (1976) 1.99
Immunoglobulin A (IgA). Methods Enzymol (1985) 1.94
A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells. J Immunol Methods (1988) 1.91
Illness doesn't belong to us. J R Soc Med (1997) 1.89
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int (1997) 1.88
General practitioner registrars' views about a career in general practice. Br J Gen Pract (1995) 1.87
Evaluating meta-ethnography: systematic analysis and synthesis of qualitative research. Health Technol Assess (2011) 1.87
Naturally occurring secretory immunoglobulin A antibodies to Streptococcus mutans in human colostrum and saliva. Infect Immun (1976) 1.85
Synergistic effect of IL-4 and IFN-gamma on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J Immunol (1990) 1.82
IgA-induced eosinophil degranulation. J Immunol (1989) 1.82
Computerized concurrent review of prenatal care. QRB Qual Rev Bull (1978) 1.81
Temporal changes in myocardial perfusion patterns in patients with reperfused anterior wall myocardial infarction. Their relation to myocardial viability. Circulation (1995) 1.81
Teaching schoolchildren cardiopulmonary resuscitation. Resuscitation (1996) 1.80
Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J Clin Microbiol (1985) 1.80
Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J Immunol (1984) 1.78
The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen. J Virol (1999) 1.76
Regulation of IgA synthesis and immune response by T cells and interleukins. J Clin Immunol (1989) 1.76
Murine model for evaluation of protective immunity to influenza virus. Vaccine (1993) 1.73
Health and medicine on television. N Engl J Med (1981) 1.73
Tissue origins of human polymeric and monomeric IgA. J Immunol (1982) 1.73
Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol (1994) 1.72
Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit. Infect Immun (1996) 1.71
Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest (1986) 1.70
Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions. J Immunol (2001) 1.69
Amniotic fluid embolism. Anaesthesia (1979) 1.69
Sickness absence and 'working through' illness: a comparison of two professional groups. J Public Health Med (1997) 1.68
Characterization of antibodies to the native human collagens and to their component alpha chains in the sera and the joint fluids of patients with rheumatoid arthritis. Immunochemistry (1976) 1.67
Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci U S A (1983) 1.67
Propofol for long-term sedation in the intensive care unit. A comparison with papaveretum and midazolam. Anaesthesia (1990) 1.67
Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest (1984) 1.65
The human IgA system: a reassessment. Clin Immunol Immunopathol (1986) 1.64
High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer. Histopathology (2003) 1.64
Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol (1993) 1.64
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. J Infect Dis (1998) 1.64
Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues. Virology (1999) 1.63
Studies on human secretory immunoglobulin A. II. Subunit structure. J Immunol (1972) 1.62
Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes. J Infect Dis (2000) 1.61